Skip to content

Phoenix EEG Amplifier A202

by Southeast Signal, Inc

Phoenix EEG Amplifier A202 is a Class II device made by Southeast Signal, Inc, cleared under FDA 510(k) K071661 on 5 Sep 2007 and listed in FDA GUDID since 29 Dec 2017 (UDI-DI B58802E0), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K071661

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB58802E0 UDI-DI Date29 Dec 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK071661 Date5 Sep 2007DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K071661 decided 5 Sep 2007 Active
  • FDA GUDID UDI-DI B58802E0 listed 29 Dec 2017 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K071661
  2. Listed FDA GUDID B58802E0

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Phoenix EEG Amplifier
Generic name
Multiple physiological signal amplifier
Model / reference
A202
Primary DI / UDI-DI
B58802E0
510(k) Number
FDA product code
HCC
GMDN term
Multiple physiological signal amplifier
Device class
Class II
Regulation number
882.5050
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code HCC (Device, Biofeedback).

Other devices from Southeast Signal, Inc

Properties

  • Single use
  • Prescription use
  • Lot / batch number
  • Serial number
  • Manufacturing date
Other properties (10, all answered No)